Recurrent and persistent hematuria with other morphologic changes
ICD-10 N02.8 is a billable code used to indicate a diagnosis of recurrent and persistent hematuria with other morphologic changes.
N02.8 refers to recurrent and persistent hematuria accompanied by other morphologic changes in the urinary system. Hematuria, defined as the presence of blood in urine, can be indicative of various underlying conditions, including nephritis, glomerulonephritis, and nephrotic syndrome. In nephritis, inflammation of the kidneys can lead to both hematuria and proteinuria, often necessitating a renal biopsy to assess the extent of kidney damage and identify specific morphologic changes. Glomerulonephritis, characterized by inflammation of the glomeruli, can present with hematuria and is often associated with significant proteinuria. The management of these conditions typically involves nephrology specialists who may prescribe immunosuppressive therapy, corticosteroids, or other medications to control inflammation and prevent further renal damage. Accurate coding of N02.8 requires a thorough understanding of the patient's clinical presentation, laboratory findings, and any relevant imaging studies, as these factors contribute to the diagnosis and treatment plan.
Detailed clinical notes on hematuria, proteinuria, and renal function tests.
Patients presenting with unexplained hematuria, nephrotic syndrome, or renal failure.
Ensure renal biopsy findings are clearly documented and correlate with the diagnosis.
Comprehensive assessment of urinary symptoms, imaging studies, and any surgical interventions.
Patients with hematuria requiring evaluation for urological malignancies or stones.
Document any urological procedures performed to rule out malignancy.
When renal biopsy is performed to assess underlying causes of hematuria.
Document indications for biopsy, findings, and any complications.
Nephrology specialists should ensure that biopsy results are linked to the diagnosis.
Morphologic changes indicate underlying kidney pathology, which can guide treatment and management strategies.
